Based on the above results, we validated the protein expression of FDX1 and DLAT in five matched normal and ccRCC clinical samples, and found that their protein expressions were poorly expressed in ccRCC tissues compared to adjacent tissues (Fig. 2D). The gene discussed is DLAT; the disease is nonpapillary renal cell carcinoma.